Table 3.
Achieving the benchmark: the number of prostate cancer cases with overall scores similar or better than the delivered clinical plan (n = 77).
VMAT T5 compared to CP | IMRT R5 compared to CP | VMAT T5 compared to R5 | |
---|---|---|---|
Similar | 4 (5.19%) | 13 (16.88%) | 10 (12.99%) |
Better | 51 (66.23%) | 33 (42.86%) | 48 (62.34%) |
Similar or better | 55 (71.43%) | 46 (59.74%) | 58 (75.32%) |
Comparisons with CP: similar = ±1 metric point on overall score; better = > 1 metric point on overall score.